RNA, U6 small nuclear 337, pseudogene (RNU6-337P)

RNU6-337P is a **pseudogene** derived from the U6 small nuclear RNA (snRNA) family. U6 snRNA is a highly conserved component of the major spliceosomal machinery, essential for pre-mRNA splicing in eukaryotes[3][1]. Unlike functional U6 genes, RNU6-337P does not produce an active snRNA molecule. Pseudogenes such as RNU6-337P are often transcriptionally silent or non-functional, but emerging evidence indicates that some pseudogenes can participate in gene regulation by acting as molecular decoys, endogenous siRNAs, or regulatory long noncoding RNAs[4]. There is no evidence that RNU6-337P has a direct biological function, nor is it considered a therapeutic target, receptor, enzyme, or transporter. Its primary relevance is in genomics, where pseudogenes are used in studies of genome evolution, genetic diversity, and potential biomarker discovery. The presence and expression of pseudogenes in various diseases, including cancer, are under investigation, with some pseudogenes implicated in disease-specific expression profiles or regulatory mechanisms[4]. **Note:** - RNU6-337P should not be confused with functional U6 small nuclear RNA or its variants; it is classified specifically as a **processed pseudogene**, and not as a receptor, enzyme, nor a direct target for drugs or therapeutic modulation[2][3][4]. - No known drugs, biomarkers, or safety concerns are associated with RNU6-337P. - Its aliases include alternative names reflecting its derivation from the U6 small nuclear RNA gene family and pseudogene status.

Other names

RNU6-337PRNA, U6 small nuclear 337, pseudogene